Azithromycin Plus Hydroxychloroquine for COVID-19 Infection
Condition(s):Respiratory Tract Infection ViralLast Updated:October 28, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Respiratory Tract Infection ViralLast Updated:October 28, 2021Withdrawn
Condition(s):COVIDLast Updated:July 28, 2020Completed
Condition(s):Recurrent Osteosarcoma; Refractory OsteosarcomaLast Updated:November 18, 2023Active, not recruiting
Condition(s):Colorectal CancerLast Updated:September 21, 2021Completed
Condition(s):Covid19; Hydroxychloroquine; Coronavirus Infection; Transmission; ProphylaxisLast Updated:December 3, 2020Completed
Condition(s):Behcet’s Syndrome, Vascular TypeLast Updated:July 25, 2019Unknown status
Condition(s):COVID19; Sars-CoV2; Hydroxychloroquine; Prophylaxis; Healthcare WorkerLast Updated:August 28, 2020Withdrawn
Condition(s):COVID-19; CancerLast Updated:October 27, 2021Terminated
Condition(s):Sars-CoV-2, Community-Acquired Pneumonia,COVID-19Last Updated:June 4, 2020Withdrawn
Condition(s):Corona Virus InfectionLast Updated:September 27, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.